Annual Cash & Cash Equivalents
$34.52 M
-$62.43 M-64.39%
December 31, 2023
Summary
- As of February 25, 2025, RGNX annual cash & cash equivalents is $34.52 million, with the most recent change of -$62.43 million (-64.39%) on December 31, 2023.
- During the last 3 years, RGNX annual cash & cash equivalents has fallen by -$303.90 million (-89.80%).
- RGNX annual cash & cash equivalents is now -90.00% below its all-time high of $345.21 million, reached on December 31, 2021.
Performance
RGNX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$56.62 M
-$1.15 M-1.99%
September 30, 2024
Summary
- As of February 25, 2025, RGNX quarterly cash and cash equivalents is $56.62 million, with the most recent change of -$1.15 million (-1.99%) on September 30, 2024.
- Over the past year, RGNX quarterly cash and cash equivalents has stayed the same.
- RGNX quarterly cash and cash equivalents is now -83.60% below its all-time high of $345.21 million, reached on December 31, 2021.
Performance
RGNX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RGNX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -64.4% | 0.0% |
| 3 y3 years | -89.8% | -75.2% |
| 5 y5 years | -54.3% | -28.9% |
RGNX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -90.0% | at low | -83.6% | +64.0% |
| 5 y | 5-year | -90.0% | at low | -83.6% | +64.0% |
| alltime | all time | -90.0% | +2985.1% | -83.6% | +4950.6% |
REGENXBIO Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $56.62 M(-2.0%) |
| Jun 2024 | - | $57.77 M(-48.9%) |
| Mar 2024 | - | $112.97 M(+227.3%) |
| Dec 2023 | $34.52 M(-64.4%) | $34.52 M(-34.9%) |
| Sep 2023 | - | $53.05 M(-22.7%) |
| Jun 2023 | - | $68.60 M(-2.1%) |
| Mar 2023 | - | $70.09 M(-27.7%) |
| Dec 2022 | $96.95 M(-71.9%) | $96.95 M(-18.2%) |
| Sep 2022 | - | $118.54 M(-2.3%) |
| Jun 2022 | - | $121.37 M(-36.7%) |
| Mar 2022 | - | $191.87 M(-44.4%) |
| Dec 2021 | $345.21 M(+2.0%) | $345.21 M(+51.2%) |
| Sep 2021 | - | $228.39 M(-11.2%) |
| Jun 2021 | - | $257.07 M(-11.8%) |
| Mar 2021 | - | $291.48 M(-13.9%) |
| Dec 2020 | $338.43 M(+386.8%) | $338.43 M(+263.0%) |
| Sep 2020 | - | $93.22 M(-1.1%) |
| Jun 2020 | - | $94.22 M(+35.7%) |
| Mar 2020 | - | $69.41 M(-0.1%) |
| Dec 2019 | $69.51 M | $69.51 M(-12.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $79.59 M(+44.3%) |
| Jun 2019 | - | $55.14 M(-1.3%) |
| Mar 2019 | - | $55.85 M(-26.1%) |
| Dec 2018 | $75.56 M(+62.0%) | $75.56 M(-46.9%) |
| Sep 2018 | - | $142.42 M(+33.2%) |
| Jun 2018 | - | $106.89 M(+48.7%) |
| Mar 2018 | - | $71.87 M(+54.0%) |
| Dec 2017 | $46.66 M(+87.8%) | $46.66 M(-22.1%) |
| Sep 2017 | - | $59.88 M(+3.9%) |
| Jun 2017 | - | $57.65 M(-29.7%) |
| Mar 2017 | - | $82.05 M(+230.3%) |
| Dec 2016 | $24.84 M(-54.1%) | $24.84 M(-11.6%) |
| Sep 2016 | - | $28.11 M(-6.6%) |
| Jun 2016 | - | $30.08 M(-15.3%) |
| Mar 2016 | - | $35.51 M(-34.4%) |
| Dec 2015 | $54.12 M(+4727.5%) | $54.12 M(-73.6%) |
| Sep 2015 | - | $205.32 M(+140.9%) |
| Jun 2015 | - | $85.22 M(+7501.7%) |
| Dec 2014 | $1.12 M(+0.2%) | $1.12 M |
| Dec 2013 | $1.12 M | - |
FAQ
- What is REGENXBIO annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for REGENXBIO?
- What is REGENXBIO annual cash & cash equivalents year-on-year change?
- What is REGENXBIO quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for REGENXBIO?
- What is REGENXBIO quarterly cash and cash equivalents year-on-year change?
What is REGENXBIO annual cash & cash equivalents?
The current annual cash & cash equivalents of RGNX is $34.52 M
What is the all time high annual cash & cash equivalents for REGENXBIO?
REGENXBIO all-time high annual cash & cash equivalents is $345.21 M
What is REGENXBIO annual cash & cash equivalents year-on-year change?
Over the past year, RGNX annual cash & cash equivalents has changed by -$62.43 M (-64.39%)
What is REGENXBIO quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RGNX is $56.62 M
What is the all time high quarterly cash and cash equivalents for REGENXBIO?
REGENXBIO all-time high quarterly cash and cash equivalents is $345.21 M
What is REGENXBIO quarterly cash and cash equivalents year-on-year change?
Over the past year, RGNX quarterly cash and cash equivalents has changed by $0.00 (0.00%)